z-logo
Premium
Waldenström macroglobulinaemia: the key questions
Author(s) -
D'Souza Anita,
Ansell Stephen,
Reeder Craig,
Gertz Morie A.
Publication year - 2013
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.12367
Subject(s) - medicine , waldenstrom macroglobulinemia , intensive care medicine , ibrutinib , pathology , immunology , leukemia , lymphoma , chronic lymphocytic leukemia
Summary In this review, the key issues that pertain to Waldenström disease are discussed in a concise question‐and‐answer format. Diagnosis, prognosis, and indications for state‐of‐the‐art therapy are updated. Current therapies presented at the 7th International Workshop for Waldenström Macroglobulinaemia are included.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here